Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Copper Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557851B reveals a novel catalytic route for Eliglustat intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.
Patent CN103772213A details a room-temperature copper-catalyzed route for (2S,3S)-2-amino-octadec-1,3-diol, offering significant cost reduction and high stereoselectivity for API manufacturing.
Patent CN118666838B enables high-purity chiral intermediates through copper-catalyzed asymmetric synthesis, offering streamlined manufacturing and enhanced supply chain reliability for pharmaceutical applications.
Breakthrough chiral copper-based catalyst enables high-yield asymmetric synthesis of optically active indole compounds with >91% ee, enhancing pharmaceutical intermediate production efficiency.
Solve low yield & high cost in beta-nitroalcohol production. Our chiral copper catalysis achieves >95% yield, 96% ee, and green ethanol solvent. Scale to 100MT/yr.
Discover how visible light-driven catalysis enables 80-90% yields with 90-99% ee for chiral alpha-unnatural amino acids, eliminating costly chiral resolution steps in drug development.